Top Story

Triglycerides examined as potential CV therapy target

October 31, 2014

BOSTON — In this video, Cardiology Today Editorial Board member Michael H. Davidson, MD, highlights a symposium at the Cardiometabolic Health Congress that examined triglycerides as a target of CV therapy.

The session included discussion of analyses of patients with high triglyceride levels and low HDL cholesterol who exhibited benefits from therapies intended to lower triglycerides, such as niacin or omega-3 fatty acids. Davidson acknowledged that the National Lipid Association and the International Atherosclerosis Society both endorse non-HDL cholesterol targets for high-risk patients, and suggested that such targets should be considered for patients with elevated triglycerides.

In the Journals

PFO closure may be cost-effective in long term

October 31, 2014
Percutaneous patent foramen ovale closure was more cost effective than medical therapy during the long term in a recent study published in the American Journal of
Meeting News Coverage

Newly donated blood reduced complications after cardiac surgery

October 31, 2014
Patients undergoing cardiac surgery experienced a lower rate of complications when receiving blood donated within 14 days, according to data presented at the Canadian…
figure Meeting News Coverage

Genetic predisposition to elevated LDL tied to aortic valve calcium, aortic stenosis

October 31, 2014
New research provides evidence of a causal association between LDL and aortic valve disease. Researchers found that genetic predisposition to elevated LDL was associated…
More News Headlines »
CME
figure

Experts’ Take: Dialogue on Hypertriglyceridemia

This activity is supported by an independent educational grant from Amarin Pharma Inc.

Lead by genetic studies, recent data describe a causal role of triglycerides (TG) in the formation of atherosclerosis…
More »
Meeting News Coverage Video
figure

Triglycerides examined as potential CV therapy target

October 31, 2014
BOSTON — In this video, Cardiology Today Editorial Board member Michael H. Davidson, MD, highlights a symposium…
More »
CME
figure

Challenges and Opportunities in the Treatment of Acute Ischemic Stroke

This activity is supported by an educational grant from Genentech.

According to the American Heart Association Heart Disease and Stroke Statistics – 2013 Update, approximately 795,000…
More »